Reln Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
RELN (Reelin) is a gene encoding the extracellular matrix protein reelin, one of the largest secreted proteins in the brain (approximately 400 kDa). Reelin plays fundamental roles in brain development, neuronal migration, synaptic plasticity, and cognitive function. Dysregulation of RELN expression and function has been strongly implicated in Alzheimer's disease (AD), Parkinson's disease (PD), schizophrenia, autism spectrum disorder, and lissencephaly 1. [1]
| Reelin | |
|---|---|
| Gene Symbol | RELN |
| Full Name | Reelin |
| Chromosome | 7q22.1 |
| NCBI Gene ID | [5649](https://www.ncbi.nlm.nih.gov/gene/5649) |
| OMIM | [600514](https://www.omim.org/entry/600514) |
| Ensembl ID | ENSG00000189056 |
| UniProt ID | [P78509](https://www.uniprot.org/uniprot/P78509) |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Lissencephaly, Schizophrenia, Autism |
Reelin is a large extracellular glycoprotein composed of multiple repeat domains. The protein contains an N-terminal signal peptide followed by 8 reelin repeat domains (R1-R8), each approximately 350 amino acids in length. The C-terminal region contains a cysteine-rich domain that is essential for receptor binding 2. [2]
Reelin is primarily secreted by Cajal-Retzius cells located in the marginal zone of the developing cerebral cortex. In the adult brain, reelin is also produced by GABAergic interneurons, particularly in the hippocampus and cerebellum. The protein is secreted into the extracellular matrix where it can diffuse and act on target neurons 3. [3]
Reelin exerts its effects by binding to two main receptor proteins on the neuronal surface: [4]
Very Low-Density Lipoprotein Receptor (VLDLR): Expressed in migrating neurons and mature neurons, VLDLR mediates reelin signaling involved in neuronal positioning and synaptic function 4.
ApoER2 (LRP8): Expressed in hippocampal and cortical neurons, ApoER2 is crucial for reelin-mediated synaptic plasticity and memory formation 5.
Upon reelin binding, these receptors cluster and activate downstream intracellular signaling cascades: [5]
Disabled-1 (DAB1) phosphorylation: The adaptor protein DAB1 binds to the cytoplasmic tails of VLDLR and ApoER2. Reelin binding induces tyrosine phosphorylation of DAB1, which is essential for downstream signaling 6.
PI3K/Akt pathway: Phosphorylated DAB1 activates PI3K, leading to Akt phosphorylation. This pathway promotes neuronal survival and regulates glycogen synthase kinase-3β (GSK-3β) activity 7.
mTOR signaling: Reelin activates mTORC1 and mTORC2, regulating protein synthesis and synaptic plasticity 8.
NMDA receptor modulation: Reelin enhances NMDA receptor function through ApoER2-mediated signaling, facilitating synaptic plasticity and long-term potentiation (LTP) 9.
During cortical development, reelin guides radially migrating neurons from the ventricular zone to their final positions in the cortical plate. This process, known as "inside-out" lamination, ensures proper cortical layering. Neurons lacking reelin or functional receptors fail to migrate properly, resulting in cortical malformation 10. [6]
In the adult brain, reelin continues to play critical roles in synaptic maintenance and plasticity: [7]
Dendritic spine formation: Reelin promotes the formation and maintenance of dendritic spines, the primary sites of excitatory synaptic transmission 11.
Long-term potentiation (LTP): Reelin enhances LTP through NMDA receptor modulation, a cellular correlate of learning and memory 12.
Synaptic scaling: Reelin regulates homeostatic synaptic scaling, helping neurons maintain stable firing rates despite changes in activity 13.
During embryonic development, reelin is highly expressed in Cajal-Retzius cells in the marginal zone of the cortex, the subplate, and the hippocampal stratum radiatum. This expression pattern guides the radial migration of neurons forming the characteristic six-layer cortical structure 14. [8]
In the adult brain, reelin expression shifts to GABAergic interneurons, particularly:
Reelin continues to be secreted at synapses, where it modulates plasticity and stability 15.
Alterations in RELN expression are observed in several neurodegenerative and psychiatric disorders:
Reelin plays a complex role in Alzheimer's disease pathogenesis:
Amyloid-beta interaction: Reelin can bind to amyloid-beta (Aβ) oligomers and potentially modulate Aβ toxicity. However, Aβ can also impair reelin signaling, creating a detrimental feedback loop 19.
Tau phosphorylation: Reelin signaling through GSK-3β can influence tau phosphorylation. Dysregulated reelin signaling may contribute to tau pathology in AD 20.
Synaptic vulnerability: Reduced reelin in AD compromises synaptic stability and plasticity, contributing to cognitive decline 21.
Therapeutic potential: Enhancing reelin signaling is being explored as a therapeutic strategy for AD. Small molecules that activate reelin receptors or stabilize reelin are under investigation 22.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Lissencephaly | Missense, nonsense | Autosomal recessive | Impaired neuronal migration, cortical layering defects |
| Schizophrenia | Promoter variants, risk SNPs | Susceptibility | Altered synaptic function, GABAergic dysfunction |
| Autism | Rare missense variants | De novo | Impaired neural circuit formation |
| Alzheimer's Disease | Expression downregulated | Acquired | Synaptic dysfunction, Aβ interaction |
In PD, reelin expression is reduced in key brain regions:
Homozygous or compound heterozygous mutations in RELN cause lissencephaly with cerebellar hypoplasia. These mutations impair reelin secretion or function, leading to severe cortical malformation 10.
Both schizophrenia and autism show reduced RELN expression in the brain:
Several therapeutic strategies targeting reelin signaling are under development:
Reelin-based therapies may be particularly effective when combined with:
Reln Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Reln Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Nakano et al. Crystal structure of reelin repeat domain, Nat Struct Mol Biol (2017). 2017. ↩︎
Botella-López et al. Reelin expression in Alzheimer's disease, J Alzheimers Dis (2008). 2008. ↩︎
Muta et al. Reelin in Parkinson's disease striatum, J Parkinsons Dis (2012). 2012. ↩︎
Fatemi et al. Reelin in schizophrenia: a neurodevelopmental hypothesis, Nat Rev Neurosci (2005). 2005. ↩︎
Pesold et al. Reelin and amyloid-beta interactions, Mol Psychiatry (2018). 2018. ↩︎
Beffert et al. Reelin and GSK3β in neuronal function, J Biol Chem (2012). 2012. ↩︎
Botella-López et al. Reelin expression in Alzheimer's disease, J Alzheimers Dis (2008). 2008. ↩︎
Puelles et al. Reelin as a therapeutic target in neurodegenerative diseases, J Mol Neurosci (2019). 2019. ↩︎